Related Experiment Video
Updated: Jul 30, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Fulminant Extra- And Intracranial Arteriovenous Thrombosis And Non-aneurysmal Subarachnoid Hemorrhage Following
Sunil V Furtado1, Nishchit Hegde1, Vinay M D Prabhu2
1Department of Neurosurgery, Ramaiah Medical College and Hospital, Bangalore, India.
Insights
COVID-19 can cause severe arteriovenous inflammation leading to extensive cerebral arteriovenous thrombosis and subarachnoid hemorrhage (SAH). This rare complication following infection carries a poor prognosis, highlighting the need for high suspicion.
Area of Science:
- Neurology
- Vascular Medicine
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) is linked to an increased risk of cerebrovascular events, including stroke and hemorrhage.
- Previous reports suggest a potential association between COVID-19 infection and thrombotic events.
Observation:
- This case report details a rare instance of fulminant panvascular arteriovenous thrombosis with subarachnoid hemorrhage (SAH) in a patient post-COVID-19 infection.
- The extensive extra- and intra-cranial thrombosis presented as a fatal, non-aneurysmal subarachnoid hemorrhage.
- Arteriovenous inflammation leading to vasculitis was identified as the likely cause of arterial rupture.
Findings:
- COVID-19 infection can precipitate severe coagulopathy.
- Extensive non-aneurysmal, non-hemispheric SAH and malignant intracranial hypertension were observed.
- The patient's outcome was poor, consistent with previous reports on non-aneurysmal SAH in COVID-19 patients.
Implications:
- Clinicians should maintain a high index of suspicion for COVID-19-induced coagulopathy presenting with severe intracranial hemorrhage.
- Early recognition and management of such vascular complications are crucial for patients with COVID-19.
- This case underscores the diverse and severe neurological manifestations of COVID-19.
Purpose:
Coronavirus disease of 2019 (COVID-19) is associated with increased risk of stroke and intracranial hemorrhage. This first report of fulminant panvascular arteriovenous thrombosis with subarachnoid hemorrhage (SAH) in a post-COVID-19 infection is attributed to extensive arteriovenous inflammation leading to arterial rupture following vasculitis.
Case Report:
We report a rare case of extensive extra- and intra-cranial cerebral arteriovenous thrombosis following COVID-19 infection, presenting as fatal non-aneurysmal subarachnoid hemorrhage. The clinical course, biochemical and radiological evaluation is discussed. The other possible etiological differentials which were analysed and ruled out during case management are also detailed.
Conclusion:
A high degree of suspicion for COVID-19 induced coagulopathy leading to extensive non- aneurysmal, non-hemispheric SAH and malignant intracranial hypertension should be entertained. Our experience and previous reports on non-aneurysmal SAH in such patients show a poor prognosis.
More Related Videos
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The Arch of Aorta
Encircling the heart, the coronary arteries form a ring-like structure before...

